Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2022 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Epstein-Barr virus: Biology and clinical disease.
Damania B, Kenney SC, Raab-Traub N. Damania B, et al. Cell. 2022 Sep 29;185(20):3652-3670. doi: 10.1016/j.cell.2022.08.026. Epub 2022 Sep 15. Cell. 2022. PMID: 36113467 Free PMC article. Review.
Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes.
Singh DR, Nelson SE, Pawelski AS, Cantres-Velez JA, Kansra AS, Pauly NP, Bristol JA, Hayes M, Ohashi M, Casco A, Lee D, Fogarty SA, Lambert PF, Johannsen EC, Kenney SC. Singh DR, et al. PLoS Pathog. 2022 Oct 3;18(10):e1010868. doi: 10.1371/journal.ppat.1010868. eCollection 2022 Oct. PLoS Pathog. 2022. PMID: 36190982 Free PMC article.
ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
Van Sciver N, Ohashi M, Nawandar DM, Pauly NP, Lee D, Makielski KR, Bristol JA, Tsao SW, Lambert PF, Johannsen EC, Kenney SC. Van Sciver N, et al. PLoS Pathog. 2021 Nov 8;17(11):e1010045. doi: 10.1371/journal.ppat.1010045. eCollection 2021 Nov. PLoS Pathog. 2021. PMID: 34748616 Free PMC article.
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.
Bristol JA, Brand J, Ohashi M, Eichelberg MR, Casco A, Nelson SE, Hayes M, Romero-Masters JC, Baiu DC, Gumperz JE, Johannsen EC, Dinh HQ, Kenney SC. Bristol JA, et al. PLoS Pathog. 2022 Apr 26;18(4):e1010453. doi: 10.1371/journal.ppat.1010453. eCollection 2022 Apr. PLoS Pathog. 2022. PMID: 35472072 Free PMC article.
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
Li C, Romero-Masters JC, Huebner S, Ohashi M, Hayes M, Bristol JA, Nelson SE, Eichelberg MR, Van Sciver N, Ranheim EA, Scott RS, Johannsen EC, Kenney SC. Li C, et al. PLoS Pathog. 2020 Jun 15;16(6):e1008590. doi: 10.1371/journal.ppat.1008590. eCollection 2020 Jun. PLoS Pathog. 2020. PMID: 32542010 Free PMC article.
B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
Romero-Masters JC, Huebner SM, Ohashi M, Bristol JA, Benner BE, Barlow EA, Turk GL, Nelson SE, Baiu DC, Van Sciver N, Ranheim EA, Gumperz J, Sherer NM, Farrell PJ, Johannsen EC, Kenney SC. Romero-Masters JC, et al. PLoS Pathog. 2020 Feb 14;16(2):e1008365. doi: 10.1371/journal.ppat.1008365. eCollection 2020 Feb. PLoS Pathog. 2020. PMID: 32059024 Free PMC article.